Randomized Phase 3 Open Label Study - Enzastaurin vs. Lomustine in Glioblastoma.
Phase of Trial: Phase III
Latest Information Update: 24 Nov 2016
At a glance
- Drugs Enzastaurin (Primary) ; Lomustine
- Indications Glioblastoma
- Focus Registrational; Therapeutic Use
- Acronyms STEERING
- Sponsors Eli Lilly
- 10 Jun 2017 Biomarkers information updated
- 22 Mar 2012 Planned end date changed from 1 Apr 2011 to 1 May 2012 as reported by ClinicalTrials.gov.
- 24 Mar 2010 Planned end date changed from Apr 2010 to Apr 2011 as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History